Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “S-1 Plus Oxaliplatin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03263741
What this trial is testing

Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Affiliated Hospital of Qinghai University 20
Large-scale testing (Phase 3)UnknownNCT03801668
What this trial is testing

Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma

Who this might be right for
Gastric Cancer
Huazhong University of Science and Technology 294
Testing effectiveness (Phase 2)Study completedNCT00525005
What this trial is testing

Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Hallym University Medical Center 44
Large-scale testing (Phase 3)UnknownNCT02512380
What this trial is testing

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

Who this might be right for
Gastric Adenocarcinoma
Chinese Academy of Medical Sciences 380
Large-scale testing (Phase 3)UnknownNCT03448549
What this trial is testing

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Stage IIIAdjuvant Chemotherapy
Peking University Cancer Hospital & Institute 1,191
Testing effectiveness (Phase 2)Looking for participantsNCT05872685
What this trial is testing

Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)

Who this might be right for
Adenocarcinoma of the StomachAdenocarcinoma of Esophagogastric JunctionProficient Mismatch Repair
Yu jiren 314
Large-scale testing (Phase 3)Looking for participantsNCT06949033
What this trial is testing

Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more
Zuoyi Jiao 668
Testing effectiveness (Phase 2)UnknownNCT01980407
What this trial is testing

Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Jilin Provincial Tumor Hospital 49
Testing effectiveness (Phase 2)Ended earlyNCT02191566
What this trial is testing

S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy

Who this might be right for
Stomach Cancer
Kangbuk Samsung Hospital 8
Testing effectiveness (Phase 2)UnknownNCT02870153
What this trial is testing

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
The First People's Hospital of Changzhou 60
Testing effectiveness (Phase 2)Ended earlyNCT01106066
What this trial is testing

Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT

Who this might be right for
Phase I: To Determine the Maximum Tolerated Dose (MTD)Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/Oxaliplatin
Samsung Medical Center 30
Early research (Phase 1)Study completedNCT03162510
What this trial is testing

Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers

Who this might be right for
Gastric Cancer in SituPancreatic CancersBiliary Cancers
National Health Research Institutes, Taiwan 18
Large-scale testing (Phase 3)Looking for participantsNCT05699655
What this trial is testing

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Who this might be right for
Immunotherapy Gastrict Cancer
Fujian Cancer Hospital 130
Testing effectiveness (Phase 2)UnknownNCT04782791
What this trial is testing

Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer

Who this might be right for
Gastric CancerChemotherapy Effect
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018063
What this trial is testing

Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer

Who this might be right for
Gastric (Cardia, Body) CancerStomach AdenocarcinomaLocally Advanced
zhoujing 35
Testing effectiveness (Phase 2)Study completedNCT04338438
What this trial is testing

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

Who this might be right for
Gastric Cancer
Beijing Friendship Hospital 37
Large-scale testing (Phase 3)Looking for participantsNCT05593458
What this trial is testing

Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1

Who this might be right for
Locally Advanced Gastric Carcinoma
Zhejiang University 190
Testing effectiveness (Phase 2)Looking for participantsNCT07504471
What this trial is testing

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Who this might be right for
Pancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital 50
Testing effectiveness (Phase 2)UnknownNCT06046963
What this trial is testing

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Who this might be right for
Gastric CancerPeritoneal MetastasesAscites, Malignant
Zhejiang Cancer Hospital 35
Testing effectiveness (Phase 2)Study completedNCT05223088
What this trial is testing

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Who this might be right for
ImmunotherapyGastrict Cancer
Fujian Cancer Hospital 40
Next Page